Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
100105432 | 10010543 | 2 | F | 20130923 | 20140324 | 20140314 | 20140331 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-20378584 | BRISTOL MYERS SQUIBB | 66.00 | YR | F | Y | 0.00000 | 20140331 | N | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
100105432 | 10010543 | 1 | PS | ELIQUIS | 1 | ORAL | D | 2J69969A | 202155 | 5 | MG | BID | |||||||
100105432 | 10010543 | 2 | C | LIPITOR | 1 | D | 0 | ||||||||||||
100105432 | 10010543 | 3 | C | METOPROLOL | 1 | D | 0 | ||||||||||||
100105432 | 10010543 | 4 | C | MOBIC | 1 | D | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
100105432 | 10010543 | 1 | Atrial fibrillation |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
100105432 | 10010543 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
100105432 | 10010543 | Anosmia | |
100105432 | 10010543 | Decreased appetite | |
100105432 | 10010543 | Hypogeusia | |
100105432 | 10010543 | Nausea | |
100105432 | 10010543 | Rotator cuff syndrome | |
100105432 | 10010543 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
100105432 | 10010543 | 1 | 20130312 | 0 |